- call +1-201-465-4211
- email sales@mrinsights.biz
Anticoagulant drugs (also known as blood thinners) are chemical substances that prevent or reduce coagulation of blood and prolong the blood clotting time.
Scope of the Report:
The worldwide market for Anticoagulant Drugs is expected to grow at a CAGR of roughly 5.0% over the next five years, will reach 31300 million US$ in 2024, from 24600 million US$ in 2019, according to a new study.
This report focuses on the Anticoagulant Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Market Segment by Manufacturers, this report covers
Bristol-Myers Squibb
Bayer
Pfizer
Johnson & Johnson
Sanofi
Boehringer Ingelheim
Daiichi Sankyo
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
NOACs
Heparin
Warfarin
Others
Market Segment by Applications, can be divided into
Hospital
Pharmacy
Other
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Anticoagulant Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Anticoagulant Drugs, with price, sales, revenue and global market share of Anticoagulant Drugs in 2017 and 2018.
Chapter 3, the Anticoagulant Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Anticoagulant Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2014 to 2019.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2014 to 2019.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2014 to 2019.
Chapter 12, Anticoagulant Drugs market forecast, by regions, type and application, with sales and revenue, from 2019 to 2024.
Chapter 13, 14 and 15, to describe Anticoagulant Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Anticoagulant Drugs Introduction
1.2 Market Analysis by Type
1.2.1 NOACs
1.2.2 Heparin
1.2.3 Warfarin
1.2.4 Others
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Pharmacy
1.3.3 Other
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2014-2024)
1.4.1.2 Canada Market States and Outlook (2014-2024)
1.4.1.3 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2014-2024)
1.4.2.2 France Market States and Outlook (2014-2024)
1.4.2.3 UK Market States and Outlook (2014-2024)
1.4.2.4 Russia Market States and Outlook (2014-2024)
1.4.2.5 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2014-2024)
1.4.3.2 Japan Market States and Outlook (2014-2024)
1.4.3.3 Korea Market States and Outlook (2014-2024)
1.4.3.4 India Market States and Outlook (2014-2024)
1.4.3.5 Southeast Asia Market States and Outlook (2014-2024)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2014-2024)
1.4.4.2 Egypt Market States and Outlook (2014-2024)
1.4.4.3 Saudi Arabia Market States and Outlook (2014-2024)
1.4.4.4 South Africa Market States and Outlook (2014-2024)
1.4.4.5 Turkey Market States and Outlook (2014-2024)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bristol-Myers Squibb
2.1.1 Business Overview
2.1.2 Anticoagulant Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Bristol-Myers Squibb Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.2 Bayer
2.2.1 Business Overview
2.2.2 Anticoagulant Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Bayer Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.3 Pfizer
2.3.1 Business Overview
2.3.2 Anticoagulant Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 Pfizer Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.4 Johnson & Johnson
2.4.1 Business Overview
2.4.2 Anticoagulant Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Johnson & Johnson Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.5 Sanofi
2.5.1 Business Overview
2.5.2 Anticoagulant Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Sanofi Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.6 Boehringer Ingelheim
2.6.1 Business Overview
2.6.2 Anticoagulant Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Boehringer Ingelheim Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
2.7 Daiichi Sankyo
2.7.1 Business Overview
2.7.2 Anticoagulant Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Daiichi Sankyo Anticoagulant Drugs Sales, Price, Revenue, Gross Margin and Market Share (2017-2018)
3 Global Anticoagulant Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2017-2018)
3.1 Global Anticoagulant Drugs Sales and Market Share by Manufacturer (2017-2018)
3.2 Global Anticoagulant Drugs Revenue and Market Share by Manufacturer (2017-2018)
3.3 Market Concentration Rate
3.3.1 Top 3 Anticoagulant Drugs Manufacturer Market Share in 2018
3.3.2 Top 6 Anticoagulant Drugs Manufacturer Market Share in 2018
3.4 Market Competition Trend
4 Global Anticoagulant Drugs Market Analysis by Regions
4.1 Global Anticoagulant Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Anticoagulant Drugs Sales and Market Share by Regions (2014-2019)
4.1.2 Global Anticoagulant Drugs Revenue and Market Share by Regions (2014-2019)
4.2 North America Anticoagulant Drugs Sales and Growth Rate (2014-2019)
4.3 Europe Anticoagulant Drugs Sales and Growth Rate (2014-2019)
4.4 Asia-Pacific Anticoagulant Drugs Sales and Growth Rate (2014-2019)
4.5 South America Anticoagulant Drugs Sales and Growth Rate (2014-2019)
4.6 Middle East and Africa Anticoagulant Drugs Sales and Growth Rate (2014-2019)
5 North America Anticoagulant Drugs by Country
5.1 North America Anticoagulant Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Anticoagulant Drugs Sales and Market Share by Country (2014-2019)
5.1.2 North America Anticoagulant Drugs Revenue and Market Share by Country (2014-2019)
5.2 United States Anticoagulant Drugs Sales and Growth Rate (2014-2019)
5.3 Canada Anticoagulant Drugs Sales and Growth Rate (2014-2019)
5.4 Mexico Anticoagulant Drugs Sales and Growth Rate (2014-2019)
6 Europe Anticoagulant Drugs by Country
6.1 Europe Anticoagulant Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Anticoagulant Drugs Sales and Market Share by Country (2014-2019)
6.1.2 Europe Anticoagulant Drugs Revenue and Market Share by Country (2014-2019)
6.2 Germany Anticoagulant Drugs Sales and Growth Rate (2014-2019)
6.3 UK Anticoagulant Drugs Sales and Growth Rate (2014-2019)
6.4 France Anticoagulant Drugs Sales and Growth Rate (2014-2019)
6.5 Russia Anticoagulant Drugs Sales and Growth Rate (2014-2019)
6.6 Italy Anticoagulant Drugs Sales and Growth Rate (2014-2019)
7 Asia-Pacific Anticoagulant Drugs by Country
7.1 Asia-Pacific Anticoagulant Drugs Sales, Revenue and Market Share by Country
7.1.1 Asia-Pacific Anticoagulant Drugs Sales and Market Share by Country (2014-2019)
7.1.2 Asia-Pacific Anticoagulant Drugs Revenue and Market Share by Country (2014-2019)
7.2 China Anticoagulant Drugs Sales and Growth Rate (2014-2019)
7.3 Japan Anticoagulant Drugs Sales and Growth Rate (2014-2019)
7.4 Korea Anticoagulant Drugs Sales and Growth Rate (2014-2019)
7.5 India Anticoagulant Drugs Sales and Growth Rate (2014-2019)
7.6 Southeast Asia Anticoagulant Drugs Sales and Growth Rate (2014-2019)
8 South America Anticoagulant Drugs by Country
8.1 South America Anticoagulant Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Anticoagulant Drugs Sales and Market Share by Country (2014-2019)
8.1.2 South America Anticoagulant Drugs Revenue and Market Share by Country (2014-2019)
8.2 Brazil Anticoagulant Drugs Sales and Growth Rate (2014-2019)
8.3 Argentina Anticoagulant Drugs Sales and Growth Rate (2014-2019)
8.4 Colombia Anticoagulant Drugs Sales and Growth Rate (2014-2019)
9 Middle East and Africa Anticoagulant Drugs by Countries
9.1 Middle East and Africa Anticoagulant Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East and Africa Anticoagulant Drugs Sales and Market Share by Country (2014-2019)
9.1.2 Middle East and Africa Anticoagulant Drugs Revenue and Market Share by Country (2014-2019)
9.2 Saudi Arabia Anticoagulant Drugs Sales and Growth Rate (2014-2019)
9.3 Turkey Anticoagulant Drugs Sales and Growth Rate (2014-2019)
9.4 Egypt Anticoagulant Drugs Sales and Growth Rate (2014-2019)
9.5 Nigeria Anticoagulant Drugs Sales and Growth Rate (2014-2019)
9.6 South Africa Anticoagulant Drugs Sales and Growth Rate (2014-2019)
10 Global Anticoagulant Drugs Market Segment by Type
10.1 Global Anticoagulant Drugs Sales, Revenue and Market Share by Type (2014-2019)
10.1.1 Global Anticoagulant Drugs Sales and Market Share by Type (2014-2019)
10.1.2 Global Anticoagulant Drugs Revenue and Market Share by Type (2014-2019)
10.2 NOACs Sales Growth and Price
10.2.1 Global NOACs Sales Growth (2014-2019)
10.2.2 Global NOACs Price (2014-2019)
10.3 Heparin Sales Growth and Price
10.3.1 Global Heparin Sales Growth (2014-2019)
10.3.2 Global Heparin Price (2014-2019)
10.4 Warfarin Sales Growth and Price
10.4.1 Global Warfarin Sales Growth (2014-2019)
10.4.2 Global Warfarin Price (2014-2019)
10.5 Others Sales Growth and Price
10.5.1 Global Others Sales Growth (2014-2019)
10.5.2 Global Others Price (2014-2019)
11 Global Anticoagulant Drugs Market Segment by Application
11.1 Global Anticoagulant Drugs Sales Market Share by Application (2014-2019)
11.2 Hospital Sales Growth (2014-2019)
11.3 Pharmacy Sales Growth (2014-2019)
11.4 Other Sales Growth (2014-2019)
12 Anticoagulant Drugs Market Forecast (2019-2024)
12.1 Global Anticoagulant Drugs Sales, Revenue and Growth Rate (2019-2024)
12.2 Anticoagulant Drugs Market Forecast by Regions (2019-2024)
12.2.1 North America Anticoagulant Drugs Market Forecast (2019-2024)
12.2.2 Europe Anticoagulant Drugs Market Forecast (2019-2024)
12.2.3 Asia-Pacific Anticoagulant Drugs Market Forecast (2019-2024)
12.2.4 South America Anticoagulant Drugs Market Forecast (2019-2024)
12.2.5 Middle East and Africa Anticoagulant Drugs Market Forecast (2019-2024)
12.3 Anticoagulant Drugs Market Forecast by Type (2019-2024)
12.3.1 Global Anticoagulant Drugs Sales Forecast by Type (2019-2024)
12.3.2 Global Anticoagulant Drugs Market Share Forecast by Type (2019-2024)
12.4 Anticoagulant Drugs Market Forecast by Application (2019-2024)
12.4.1 Global Anticoagulant Drugs Sales Forecast by Application (2019-2024)
12.4.2 Global Anticoagulant Drugs Market Share Forecast by Application (2019-2024)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Anticoagulant Drugs Picture
Table Product Specifications of Anticoagulant Drugs
Figure Global Sales Market Share of Anticoagulant Drugs by Types in 2018
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
